H. Moses Murdock, MD¹, Haesook T. Kim, PhD², Katie Maurer, MD, PhD¹, Amar H. Kelkar, MD, MPH, FACP¹, Roman M. Shapiro, MD¹, Mahasweta Gooptu, MD³, Rizwan Romee, MD¹, Corey S. Cutler, MD, MPH¹, John Koreth, MD, MBBS, PhD, DPhil¹, Jerome Ritz, MD¹, Joseph H. Antin, MD¹, Vincent T. Ho, MD^1*, Sarah Nikiforow, MD, PhD¹, Catherine J. Wu, MD^1* and Robert J. Soiffer, MD¹

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
³Department of Hematology/Oncology, Dana-Farber Cancer Institute, Boston, MA

Yimei Feng^1*, Yijie Wang, PhD^2*, Xiaobo Li^2*, Da Di, PhD^3*, Xiangjun Liu, PhD^2* and Xi Zhang, PhD¹

¹Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqin, China
²Beijing BFR Gene Diagnostics LTD., Beijing, China
³Department of Genetics and Evolution–Anthropology Unit, University of Geneva, Geneva, Switzerland

Anna Eichinger, MD^1*, Zofia Szmit, MD, PhD^2*, Katharina Kleinschmidt, MD^3*, Mouad Abouqateb, MSc, MPH^4*, Marc Ansari, MD, PhD⁵, Peter Bader⁶, Adriana Balduzzi, MD^7,8, Marc Bierings, MD, PhD⁹, Arnaud Dalissier, BSc^4*, Jean-Hugues Dalle, MD, PHD¹⁰, Cristina Díaz De Heredia^11*, Franca Fagioli, MD, PhD^12*, Maura Faraci, MD^13*, Jacques-Emmanuel Galimard, PhD^4*, Brenda Gibson, MD^14*, Peter Lang, MD^15*, Oana Mirci-Danicar, MD, PhD^16*, Richard Mitchell, MBBS^17*, Christina Peters^18*, Kanchan Rao^19*, Samppa Ryhänen, MD, PhD^20*, Martin G. Sauer, MD²¹, Petr Sedlacek, MD, PhD^22*, Jan Styczynski, MD, PhD^23*, Selim Corbacioglu, MD^3* and Krzysztof Kalwak, MD, PhD^24*

¹Department of Pediatrics, Dr. von Hauner Children’s Hospital, University Hospital, LMU, Munich, Germany
²Department of Pediatric Hematology, Oncology and BMT, Wroclaw Medical University, Wrocław, Poland
³Department of Pediatric Oncology, Hematology and Stem Cell Transplantation, University Children’s Hospital Regensburg, Regensburg, Germany
⁴EBMT Paris Study Unit, Saint Antoine Hospital, INSERM UMR-S 938, Sorbonne University, Paris, France
⁵Department of Pediatrics, Onco-Hematology Unit,, Geneva University Hospital, Geneva, Switzerland
⁶Department of Pediatrics, Division for Stem Cell Transplantation and Immunology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany
⁷Fondazione IRCCS San Gerardo dei Tintori, Pediatric Hematopoietic Stem Cell Transplant Unit, Monza, Italy
⁸University of Milano-Bicocca, Monza, Italy
⁹Princess Maxima Center/ University Hospital for Children (WKZ), Stem cell transplantation, Utrecht, Netherlands
¹⁰Hôpital Robert Debre, Pediatric Hematology and Immunology Department, GHU AP-HP Nord – Université Paris Cité, Paris, France
¹¹Department of Pediatric Hematology and Oncology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
¹²Ospedale Infantile Regina Margherita, Torino, Italy, Torino, Italy
¹³HSCT Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy
¹⁴Department of Paediatric Haematology, Royal Hospital for Sick Children, Glasgow, United Kingdom
¹⁵Department of Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany
¹⁶Bristol Royal Hospital for Children Dept. of Paediatric Haematology/Oncology/BMT, Bristol, United Kingdom
¹⁷Kids Cancer Centre, Sydney Children`s Hospital, Randwick, Australia
¹⁸Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, St. Anna Children's Hospital, St. Anna Children's Hospital, Vienna, Austria
¹⁹Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
²⁰Pediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
²¹Hannover Medical University, Hannover, Germany
²²University Hospital Motol, Department of Paediatric Haematology and Oncology, Prague, Czech Republic
²³University Hospital, Collegium Medicum UMK Pediatric Hematology and Oncology, Bydgoszcz, Poland
²⁴Department of Pediatric Hematology, Oncology and BMT, Wroclaw Medical University, Wroclaw, Poland

Hiroaki Shimizu, MD, PhD¹, Yuho Najima, MD, PhD², Shinichi Kako, MD, PhD³, Takayoshi Tachibana, MD, PhD^4*, Akihiko Izumi^5*, Susumu Tanoue^6*, Emiko Sakaida, MD PhD⁷, Takuya Miyazaki, MD, PhD^8*, Katsuhiro Shono, MD, PhD^9*, Kota Yoshifuji, MD, PhD^10*, Shinichiro Machida^11*, Takashi Toya, MD, PhD^1*, Noriko Doki¹, Satoru Takada, MD^12*, Kaoru Hatano^13*, Jun Kato, MD, PhD^14*, Satoshi Takahashi, MD, PhD¹⁵, Jun Taguchi^16*, Shingo Yano, MD, PhD¹⁷ and Yoshinobu Kanda, MD, PhD^3,18*

¹Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
²Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, TKY, JPN
³Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
⁴Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan
⁵Kanagawa Cancer Center, Yokohama, JPN
⁶Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Kashiwa-Shi, CHI, Japan
⁷Department of Hematology, Chiba University Hospital, Chiba City, Japan
⁸Department of Hematology, Yokohama City University Medical Center, Kanagawa, Japan
⁹Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan
¹⁰Department of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Bunkyo-Ku, TKY, JPN
¹¹Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan
¹²Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan
¹³Jichi Medical University Hospital, Shimotsuke city, Tochigi, JPN
¹⁴Division of Hematology, Keio university school of medicine, Shinjuku-Ku, JPN
¹⁵The Institute of Medical Science Hospital, Department of Hematology/Oncology, The University of Tokyo, Tokyo, Japan
¹⁶Department of Hematology, Japanese Red Cross Shizuoka Hospital, Shizuoka, Japan
¹⁷Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
¹⁸Division of Hematology, Jichi Medical University, Tochigi, Japan

Hiroyuki Kubo^1*, Osamu Imataki^1*, Tetsuya Fukumoto^2*, Tomoya Ishida^1*, Yukiko Hamasaki Kubo^3*, Maki Oku^3*, Yui Kawanaka^1*, Yu Suezawa^1*, Shunsuke Yoshida^1*, Shumpei Uchida^1*, Makiko Uemura^1*, Haruyuki Fujita^1* and Norimitsu Kadowaki, M.D., Ph.D.¹

¹Kagawa University, Kita-County, Japan
²Takamatsu Red Cross Hospital, Takamatsu, Japan
³Kagawa Prefectural Central Hospital, Takamatsu, Japan

Muhammad Umair Mushtaq^1,2,3, Amir Kasaeian^1,3*, Sibgha Gull Chaudhary, MD^1,2,3*, Muhammad Kashif Amin, MD^1,2,3*, Naghmeh Khavandgar^1,3*, Hediyeh Alemi^1,3*, Muhammad Fareed Khalid, MD^1,3*, Iqra Anwar, MBBS^1,3*, Matthew McGuirk^1,2*, Al-Ola Abdallah, MD^1,2,3, Anurag K. Singh, MD^1,2,3, Mehdi Hamadani, MD^3,4, Joseph P. McGuirk, DO^1,2,3 and Moazzam Shahzad, MD^3,5

¹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
²US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
³Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
⁴Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁵Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL

Yongqiang Zhao^*, Yanzhi Song^*, Zhihui Li^*, Feifei Li^*, Dongfang Yang^*, Rui Wang^*, Fang Fang^*, Huiyu Li^* and Tong Wu, MD

Department of Bone Marrow Transplantation, Beijing GoBroad Boren Hospital, Beijing, China

Elisa Roldan, MD^1,2*, Alba Puyuelo, MD^3,4*, Sergi Camarillas, MD^5*, Olga Salamero, MD^4,6,7*, Ana Perez Gonzalez, MD^8,9*, Maria Laura Fox, MD^10,11*, Felix Lopez, MD^12*, Maria Sola, MD^13*, Pere Barba, MD^14,15,16, Guillermo Orti, MD, PhD^17* and David Valcarcel, MD, PhD^6,10

¹Autonomous University of Barcelona., Barcelona, Spain
²Sheffield Teaching Hospitals NHS Foundation Trust. Sheffield, United Kingdom, Sheffield, United Kingdom
³Vall D'Hebron University Hospital, Hematology Department, Barcelona, Spain
⁴Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
⁵Vall d'Hebron University Hospital, Barcelona, Spain
⁶Department of Hematology, Vall d’Hebron University Hospital, Barcelona, Spain
⁷Hematology Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
⁸Department of Hematology, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Barcelona, Spain
⁹Vall d´Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebrón, Barcelona, Spain
¹⁰Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
¹¹Hematology Department, Vall d'Hebron University Hospital, University Autònoma of Barcelona (UAB), Barcelona, Spain
¹²Vall D'Hebron Universitary Hospital, Barcelona, Spain
¹³Department of Hematology, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
¹⁴Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
¹⁵Vall d’Hebron Institute of Oncology (VHIO), Department of Hematology, University Hospital Vall d'Hebron, Universitat Autònoma of Barcelona (UAB), Barcelona, Spain
¹⁶Department of Hematology, Hospital Universitari Vall d'Hebron, Barcelona, Spain
¹⁷Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Ruijuan Sun^1,2*, Yue Lu^1,3*, Jian-Ping Zhang^1,3*, Jiarui Zhou^1,3*, Deyan Liu^1,3*, Yanli Zhao^1,3*, Zhijie Wei^1,3*, Min Xiong^1,3*, Xingyu Cao^1,3* and Peihua Lu, MD^1,3,4

¹Beijing Lu Daopei Hospital, Beijing, China
²Hebei Yanda Lu Daopei Hospital, Beijing, China
³Hebei Yanda Lu Daopei Hospital, Langfang, China
⁴Beijing Lu Daopei Institute of Hematology, Beijing, China

Kristin Rathje^1*, Kordelia Barbullushi, MD^2*, Nico Gagelmann, MD^3*, Anita Badbaran, M. Sc.^4*, Johanna Richter^4*, Mathias Schäfersküpper^4*, Franziska Elisabeth Marquard, M.D.^4*, Radwan Massoud, MD, BS^5*, Sofia Oechsler^6*, Evgeny Klyuchnikov, M.D.^3*, Ina Rudolph^4*, Silke Heidenreich, MD^4*, Christian Niederwieser, M.D.^3*, Catherina Lück, M.D.^4*, Dietlinde Janson, M.D.^4*, Christine Wolschke, M.D.^4*, Boris Fehse, PhD^4*, Francis A. Ayuk, M.D.^4* and Nicolaus Kroeger, M.D.⁴

¹Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, AL, Germany
²SC Ematologia, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy
³Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany
⁴Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁵Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Hamburg, Germany
⁶University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Eva Rettinger, MD^1*, Martin Hutter^1*, Birte Karschen^2*, Evangelia Antoniou, MD³, Peter Bader, MD¹, Rita Beier, MD^4*, Birgit Burkhardt, MD, PhD⁵, Ursula Creutzig^4*, Gabriele Escherich^6*, Jan-Henning Klusmann, MD⁷, Peter Lang, MD^8*, Naghmeh Niktoreh, MD^2*, Martin G. Sauer, MD⁴, Stephanie Sendker, MD^3*, Dirk Reinhardt, MD² and Katharina Waack^9*

¹Department of Pediatrics, Goethe University Frankfurt, Frankfurt, Germany
²University Medicine Essen, University Children’s Hospital III, AML BFM Study Group, Essen, Germany
³University Children’s Hospital Essen. Department of Pediatric Hematology and Oncology, Essen, Germany
⁴Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany
⁵University Hospital Muenster, Department of Paediatric Hematology, Oncology and BMT and NHL-BFM study center, Münster, Germany
⁶Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁷Department of Pediatrics, Goethe University Frankfurt, Frankfurt, Hessen, Germany
⁸Department of Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany
⁹Pediatric Research Network, AML BFM Study Group, Essen, Germany

Kate Stringaris, MB BS, BSc, PhD, MRCP, FRCPath^*, Michele Robinson, MBChB, MRCOG^*, Melanie C Davies, MA , MRCP, FRCOG^*, Anna L David, MB ChB, PhD, FRCOG^* and Panagiotis Kottaridis, FRCPath, PhD, MSc^*

University College London Hospitals, London, United Kingdom

Thuy T Koll, M.D.^1*, Megan Kerns, B.S.^1*, Tanya M. Wildes, MD, MSc¹, Vijaya Raj Bhatt, MD², Krishna Gundabolu, MBBS³, Lori Maness, MD⁴, Michael Haddadin, MBBS⁴, Marcia Free, BSN^1*, Elizabeth R Lyden, PhD^5*, Daniel L Murman, M.D.^5* and Alfred L Fisher, M.D.^6*

¹University of Nebraska Medical Center, Omaha, NE
²The Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE
³Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center College of Medicine, Omaha, NE
⁴Fred & Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, NE
⁵University of Nebraska Medical Center, Omaha
⁶University Of Nebraska Medical Center, Omaha, NE

Jonathan Allen Webster, MD¹, Madison C Reed, MD^2*, Hua-Ling Tsai, Sc.M^3*, Philip Imus, MD⁴, B. Douglas Smith, MD¹, Alexander J. Ambinder, MD, MPH¹, Mark J. Levis¹, Amy E. DeZern, MD⁵, Gabrielle T. Prince, MD^1*, Javier Bolanos-Meade, MD^6*, Lukasz P. Gondek, MD, PhD¹, Gabriel Ghiaur, MD, PhD⁷, William Brian Dalton, MD, PhD¹, Theodoros Karantanos, MD, PhD¹, Suman Paul, MBBS, PhD⁸, Ephraim Joseph Fuchs, MD, MBA⁴, Cole Sterling, MD⁹, Lode J. Swinnen, MBCHB¹⁰, Nina D. Wagner-Johnston, MD¹¹, Richard F. Ambinder, MD¹², Christian B. Gocke, MD, PhD¹³, Syed Abbas Ali¹, Carol Ann Huff^13*, Leo Luznik, MD¹⁴, Ravi Varadhan^15*, Richard J. Jones, MD⁴ and Ivana Gojo, MD¹

¹Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
²Department of Internal Medicine, Yale University School of Medicine, New Haven, CT
³Division of Biostatistics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
⁴Johns Hopkins University, Baltimore, MD
⁵Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
⁶Johns Hopkins University Kimmel Cancer Center, Ellicott City, MD
⁷Division of Hematologic Malignancies, Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, John's Hopkins Hospital, Baltimore, MD
⁸Division of Hematologic Malignancies, Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD
⁹Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
¹⁰Johns Hopkins Cancer Center, Baltimore, MD
¹¹Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD
¹²Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD
¹³Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
¹⁴Sidney Kimmel Comprehensive Cancer Ctr., Baltimore, MD
¹⁵Johns Hopkins, Baltimore, MD

Moazzam Shahzad, MD^1,2, Sohaib Irfan, MD^2,3*, Muhammad Kashif Amin, MD^2,3,4*, Muhammad Jawad Javed, MBBS^2,3, Matthew McGuirk^2,3*, Sibgha Gull Chaudhary, MD^2,3,4*, Iqra Anwar, MBBS^2,3*, Zobia Farooq^2,3*, Abdulraheem Yacoub, MD^2*, Anurag K. Singh, MD^2,3,4, Mehdi Hamadani, MD⁵, Joseph P. McGuirk, DO^2,3,4 and Muhammad Umair Mushtaq^2,3,4

¹Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
²Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
³Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
⁴US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
⁵Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Yu-Han Chen, MD¹, Andrea Yue-En Sun^2*, Karishma Narain, MD^1*, Natasha Rastogi, MD^1* and Cho-Hao Lee, MD^3*

¹Department of Internal Medicine, Englewood Hospital and Medical Center, Englewood, NJ
²College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
³Division of Hematology and Oncology Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Taipei, Taiwan

Osama Ahmad^1*, Jan Frederic Weller, MD^1*, Nicolaus Kröger, MD^2*, Eva Wagner Drouet^3*, David Nachbaur, M.D.^4*, Normann Steiner^4*, Daniel Teschner, MD^5*, Sabrina Kraus^5*, Gesine Bug^6*, Salem Ajib^6*, Johannes Schetelig, MD, MSc⁷, Wolfgang Andreas Bethge, MD^8*, Thomas Schroeder^9*, Judith Schaffrath, MD^10*, Lutz Peter Hermann Mueller, MD^11*, Mareike Verbeek, MD^12*, Edgar Jost, MD^13*, Hatice Soysal, MD^13*, Georg-Nikolaus Franke, MD^14*, Stefan Klein, MD¹⁵, Udo Holtick^16*, Knut Wendelin^17*, Claudia Lengerke, MD¹⁸, Martin Bornhäuser, MD^7* and Maximilian Christopeit^1,19*

¹Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
²University Medical Center Hamburg, Hamburg, Germany
³Universitätsmedizin der Johannes Gutenberg-Universität, Mainz, Germany
⁴University Hospital of Internal Medicine V (Hematology and Oncology), Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria
⁵Division of Hematology, University Hospital of Wurzburg, Wurzburg, Germany, Würzburg, Germany
⁶Dept. of Medicine 2, University Hospital, Goethe University Frankfurt, Frankfurt, Germany
⁷Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
⁸Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tübingen, Germany
⁹Dept. of Hematology and Stem Cell Transplantation West German Cancer Centre University Hospital Essen Essen, Germany, Essen, Germany
¹⁰Department of Internal Medicine IV, Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle, Germany
¹¹Department of Internal Medicine IV, University Hospital Halle Martin Luther, University Halle-Wittenberg, Halle, Germany
¹²Department of Medicine III, Hematology and Oncology, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany
¹³Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, RWTH Aachen University, Medical Faculty, Aachen, Germany
¹⁴Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
¹⁵Universitätsmedizin Mannheim, Mannheim, Germany
¹⁶Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany
¹⁷Med Clinic 5, Klinikum Nürnberg, Nuernberg, Germany
¹⁸Department for Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
¹⁹University Cancer Center Hamburg, Department of Medicine II - Oncology, Hematology and Bone Marrow Transplantation With Section Pneumology, Hamburg, Germany

Qamar Iqbal, MD^1*, Sohaib Irfan, MD^2*, Ahmad Basharat^3*, Prashil Dave, MBBS⁴, Ahmed Hebishy, MBBCh⁵, Muhammad Kashif Amin, MD^6*, Muhammad Umair Mushtaq⁷ and Moazzam Shahzad, MD⁸

¹Hospitalist, TidalHealth, Salisbury, MD
²Aga Khan University, Karachi, Pakistan
³Marshfield Clinic Health System, Marshfield, Wisconsin, Marshfield, WI
⁴SUNY Downstate Health Sciences University, Brooklyn, NY
⁵East Carolina University/Brody School of Medicine, Greenville, NC
⁶Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
⁷Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
⁸H Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Moazzam Shahzad, MD^1,2, Zouina Sarfraz, MBBS^1,3*, Ben Ponvilawan, MD^1,3*, Muhammad Kashif Amin, MD^1,3,4*, Ankita Gupta, MD^1,3*, Matthew McGuirk^1,3*, Sibgha Gull Chaudhary, MD^1,3,4*, Iqra Anwar, MBBS^1,3*, Leyla O. Shune, MD^1,4,5, Joseph P. McGuirk, DO^1,3,4, Mehdi Hamadani, MD⁶ and Muhammad Umair Mushtaq^1,3,4

¹Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
²Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
³Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
⁴US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
⁵University of Kansas Medical Center, Kansas City, KS
⁶Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Thi Thuy Duong Pham, BS^1,2,3*, Su-Young Choi, BS^1,2,3*, Buyeon Heo, BS^1,2,3*, Sang-Woo Lee^1*, Myung-Won Lee, MD⁴, Jung-Hyun Park, PhD^5*, Yunseon Jang, PhD^5*, Deog-Yeon Jo, MD, PhD⁴, Jaeyul Kwon, PhD^1,2,3,5*, Ik Chan Song, MD, PhD^1,3,4,5 and Jeong Suk Koh^6*

¹Department of Medical Science, College of Medicine, Chungnam National University, Daejeon, Korea, Republic of (South)
²Department of Infection Biology, College of Medicine, Chungnam National University, Daejeon, Korea, Republic of (South)
³Brain Korea 21 FOUR Project for Medical Science, College of Medicine, Chungnam National University, Daejeon, Korea, Republic of (South)
⁴Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Korea, Republic of (South)
⁵Translational Immunology Institute, College of Medicine, Chungnam National University, Daejeon, Korea, Republic of (South)
⁶Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, FL, South Korea